ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Trial Finds Reduction in Depressive Symptoms Following Magnesium Supplementation

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

Carnitine deficiency suggested as contributor to autism

Vitamin D supplement use associated with lower risk of breast cancer

Hop Oil: A Safe Sleep Aide

White Camphor Oil: The Purest Camphor Oil

Lutein — An Important Nutrient for Eye and Brain Health

 
Print Page
Email Article

Say NO to Fibromyalgia and Chronic Fatigue Syndrome: An Alternative and Complementary Therapy to Aerobic Exercise

  [ 759 votes ]   [ Discuss This Article ]
www.ProHealth.com • June 30, 2004


Acceleration Therapeutics' AT-101 Provides Symptomatic Relief in Fibromyalgia & Chronic Fatigue Syndrome NORTH BAY VILLAGE, Fla.---June 24, 2004--Acceleration Therapeutics, a Division of Non-Invasive Monitoring Systems, Inc. (NIMS), announces the publication of a study which showed significant improvements in Role Physical, Bodily Pain, and Vitality for patients with Fibromyalgia and Chronic Fatigue Syndrome.

Patients were assessed using a health-related quality of life questionnaire. These benefits are attributed to release of nitric oxide (NO) from the inner lining of blood vessels into the circulation produced with the AT-101. The study, entitled "Say NO to Fibromyalgia and Chronic Fatigue Syndrome: An Alternative and Complementary Therapy to Aerobic Exercise," used the company's flagship product, the AT-101. The results are published in the July 2004 Medical Hypotheses. The study is authored by the company's President, Marvin A Sackner, M.D. Since NO has a documented anti-inflammatory action, such results are consistent with the notion that these diseases have chronic inflammation as their basis. Dr. Sackner and Dr. Tony Adams, Mt. Sinai Medical Center of Greater Miami, also presented two AT-101 papers at an international symposium in Rio de Janeiro, Brazil on Nitric Oxide, Cytokines and Inflammation, June 6-9, 2004. They found similar symptomatic improvements in osteoarthritis and chronic neurological diseases.

The AT-101 is a platform that moves the body repetitively head to foot at a rapid, yet comfortable pace. Acceleration Therapeutics, a division of NIMS, markets the AT-101 worldwide. The AT-101 is listed with the FDA as a Class I (exempt) passive exercise device intended as an aid to improve the circulation and joint mobility. AT-101 treatments are reimbursed by Medicare and insurance companies under CPT 97110, Therapeutic Exercises, which requires that patients have one of the following, a chronic neurological disease including fibromyalgia or chronic fatigue syndrome, rheumatological disease, soft tissue injury or bone fracture.

STUDY ABSTRACT: Say NO to fibromyalgia and chronic fatigue syndrome: an alternative and complementary therapy to aerobic exercise Marvin A. Sackner, Emerance M. Gummels and Jose A. Adams Mt. Sinai Medical Center of Greater Miami, Division of Pulmonary Disease and Critical Care Medicine and Department of Neonatology, Miami Beach, FL 33140, USA Received 28 January 2004; accepted 31 January 2004. Available online 15 April 2004.

Increased shear stress to the endothelium increases activity of endothelial nitric oxide synthase (eNOS) with subsequent release of small quantities (nMol) of nitric oxide (NO) into the circulation. It occurs during moderate aerobic exercise mostly as a result of laminar shear stress and with whole body, periodic acceleration as a result of pulsatile shear stress. The latter is administered by means of a new, non-invasive, passive exercise device. Moderate exercise has long been known to alleviate the symptoms of fibromyalgia and chronic fatigue syndrome and in the current study, whole body, periodic acceleration did as well. Since NO through action of eNOS has potent anti-inflammatory properties mainly by suppressing nuclear factor Kb activity, it is hypothesized that both diseases have chronic inflammation as their basis. Whole body periodic acceleration can be applied separately or supplementary to aerobic exercise in the treatment of fibromyalgia and chronic fatigue syndrome.

Copyright © 2004 Elsevier Ltd. All rights reserved

Acceleration Therapeutics (www.accelerationtherapeutics.com) is a leading developer of scientifically-advanced medical devices that offer effective non-invasive, drug-free treatments for people suffering from diseases, conditions and injuries that cause limited mobility or impaired circulation. The Company's first product, the AT-101, consists of a comfortable platform upon which a supine person experiences a repetitive back and forth motion from head to foot. This device can be used in a home, clinic or hospital setting. The AT-101 is registered with the FDA as a Class 1 (exempt) device. Acceleration Therapeutics is a division of Nims, Inc. (OTCBB: NIMU) a South Florida based, publicly traded company that has developed several successful products for the health care market.

Contact: Deborah Goldring, 305-861-0075 Acceleration Therapeutics dgoldring@accelerationtherapeutics.com

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.



Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Optimized Curcumin Longvida® Mitochondria Ignite™ with NT Factor®


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Restoring Gut Health: How to Create a Firewall Against Toxins Entering the Gut Wall Restoring Gut Health: How to Create a Firewall Against Toxins Entering the Gut Wall
Repair Damaged Mitochondria and Reduce Fatigue Up to 45% Repair Damaged Mitochondria and Reduce Fatigue Up to 45%
Research Links Green Tea to Weight Loss Research Links Green Tea to Weight Loss
Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea
D-ficient? Health Risks You Need to Know About D-ficient? Health Risks You Need to Know About

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map